PYPL
41
2
LB
30
-8
VLO
33
4
IRM
65
2
MDT
59
-3
WHR
64
3
MRK
25
2
AA
43
2
SLB
46
2
DAL
77
-3
AAPL
42
5
KEY
33
-4
TAP
51
6
VFC
65
2
HRB
54
2
LOW
50
4
PNR
65
3
NVDA
54
2
COP
54
4
VMC
57
-5
PYPL
41
2
LB
30
-8
VLO
33
4
IRM
65
2
MDT
59
-3
WHR
64
3
MRK
25
2
AA
43
2
SLB
46
2
DAL
77
-3
AAPL
42
5
KEY
33
-4
TAP
51
6
VFC
65
2
HRB
54
2
LOW
50
4
PNR
65
3
NVDA
54
2
COP
54
4
VMC
57
-5
Financhill
Back

Black Diamond Therapeutics 10K Form

Sell
34

BDTX
Black Diamond Therapeutics

Last Price:
3.26
Seasonality Move:
8.38%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive BDTX News And Ratings

See the #1 stock for the next 7 days that we like better than BDTX

BDTX Financial Statistics

Sales & Book Value

Annual Sales: --
Cash Flow: $-14.73M
Price / Cash Flow: 0
Annual Sales: $1.97
Price / Book: 1.52

Profitability

EPS (TTM): -1.50000
Net Income (TTM): $-80.55M
Gross Margin: --
Return on Equity: 0%
Return on Assets: 0%

Black Diamond Therapeutics Earnings Forecast

Key Black Diamond Therapeutics Financial Ratios

  • The Interest Expense is 0.00% of Operating Income.
  • Per Share Earnings over the last 7 years have been positive in 2 years.

Black Diamond Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: BDTX
CUSIP: 09203E
Website: blackdiamondtherapeutics.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

BDTX Technical Analysis vs Fundamental Analysis

Sell
34
Black Diamond Therapeutics (BDTX) is a Sell

Is Black Diamond Therapeutics a Buy or a Sell?